EUVIMEDEUVIMED entdecken
Crossref

Impact of a free medication intervention on seizure recurrence and anxious and depressive symptoms in people living with epilepsy in the Republic of Guinea

Dylan R Rice, Carlos Othon Guelngar, Mohamed Traoré, Mohamed Laminé Condé, Djenabou Diallo, Nathanael J Lee, Andrew Siyoon Ham iD, Fodé Abass Cissé, Farrah J Mateen, Guinea Epilepsy Project

Tropical Medicine & International Health · 2024

DOI: 10.1111/tmi.13950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tropical Medicine & International Health, 2024. Verfasst von Dylan R Rice und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Depression, Epilepsy. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Fondation Pierre Fabre, United States Embassy in Guinea, Massachusetts General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Of ~5 million people living with epilepsy (PLWE) in Sub‐Saharan Africa, roughly one‐third experience depression and over one third experience anxiety. In Guinea, these issues may be compounded by fewer available resources, such as appropriate anti‐seizure medications (ASMs). We aim to quantify seizure frequency, anxiety and depression in PLWE in Guinea, before and after a free ASM intervention and neurologist's consultation.

Methods

Guinean participants >12 years old with ≥2 unprovoked seizure were prospectively recruited. As part of a broader interview, participants reported prior 30‐day seizure frequency and screened for depression (PHQ‐9) (range 0–27 points) and anxiety (GAD‐7) (range 0–21 points) with re‐evaluation at 90 days.

Results

Of 148 participants enrolled (mean age = 27.3 years, range 12–72; 45% female), 62% were currently taking ASMs. For the 30 days pre‐enrolment, average seizure frequency was 3.2 (95%CI 2.3, 4.2); 28% of participants were seizure‐free. ASM regimens were modified for 95% of participants, mostly initiating levetiracetam ( n = 115, 80% of modifications). 90‐day study retention was 76% ( n = 113) among whom 87% reported full adherence to the ASM. After 90 days, the average seizure frequency over the prior 30 days was 1.5 (95%CI 0.5, 2.6), significantly lower than at baseline ( p = 0.002). 66% were seizure‐free. At baseline, average PHQ‐9 score was 21.2 (95%CI [20.2, 22.2]), indicating severe depressive symptoms. Average GAD‐7 score was 16.5 [15.6, 17.4], indicating severe anxious symptoms. At 90‐days, average PHQ‐9 score was 17.5[16.4, 18.5] and significantly lower than baseline ( p < 0.001). Average GAD‐7 score was 14.4 [13.6, 15.3] and significantly lower than baseline ( p = 0.002). Seizure frequency was not correlated with PHQ‐9 nor GAD‐7 scores at baseline but was at 90 days for both PHQ‐9 ( r = 0.24, p = 0.01) and GAD‐7 ( r = 0.22, p = 0.02) scores. The prevalence of suicidal ideation dropped from 67% to 47% of participants ( p = 0.004).

Discussion

ASM management has dual importance for PLWE in resource‐limited settings, improving both seizure control and mental health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionEpilepsyHumansFemaleChildAdolescentYoung AdultAdultMiddle AgedAgedMaleGuineaAnxietySeizures

Stichwörter der Autor:innen

Africaanxietydepressionepilepsyglobal healthtreatment

Autor:innen und Institutionen

  • Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Neurology, Ignace Deen Teaching Hospital, Conakry, Republic of Guinea.
  • Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Andrew Siyoon Ham

Förderung

  • Fondation Pierre Fabre
  • United States Embassy in Guinea
  • Massachusetts General Hospital

Zitieren

APA

Rice, D. R., Guelngar, C. O., Traoré, M., Condé, M. L., Diallo, D., Lee, N. J., Ham, A. S., Cissé, F. A., Mateen, F. J., & Guinea Epilepsy Project (2024). Impact of a free medication intervention on seizure recurrence and anxious and depressive symptoms in people living with epilepsy in the Republic of Guinea. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.13950

Vancouver

Rice DR, Guelngar CO, Traoré M, Condé ML, Diallo D, Lee NJ, et al. Impact of a free medication intervention on seizure recurrence and anxious and depressive symptoms in people living with epilepsy in the Republic of Guinea. Tropical Medicine & International Health. 2024. doi:10.1111/tmi.13950

BibTeX
@article{Rice2024,
  author = {Rice, Dylan R and Guelngar, Carlos Othon and Traoré, Mohamed and Condé, Mohamed Laminé and Diallo, Djenabou and Lee, Nathanael J and Ham, Andrew Siyoon and Cissé, Fodé Abass and Mateen, Farrah J and Guinea Epilepsy Project, Guinea Epilepsy Project},
  title = {Impact of a free medication intervention on seizure recurrence and anxious and depressive symptoms in people living with epilepsy in the Republic of Guinea},
  journal = {Tropical Medicine & International Health},
  year = {2024},
  doi = {10.1111/tmi.13950}
}
Kostenlos starten →